20th July 2022 | Pharma Updates
India will launch two programs that help the pharma business, according to the Center
To increase India’s manufacturing capabilities in the pharmaceuticals business, the government is getting ready to launch programmes to develop the sector with an emphasis on MSMEs and clusters.
Lacking a drug control administration, CDSCO powerless to oversee Lakshadweep's drug supply
The Central Drugs Standard Control Organization (CDSCO) has stated that they are unable to keep track of the drug supplies in the Lakshadweep islands or establish a drug control system there.
With Sandoz unit still under investigation, Novartis no longer anticipates declining earnings
Novartis predicted that Sandoz’s earnings this year would likely be unchanged, no longer anticipating a drop, and noted that the strategic review was proceeding according to schedule.
Pharma Industry's Digital Marketing: Best Practices and Compliance
Digital healthcare marketing is becoming the most popular and quickly growing sector as pharma companies adapt to shifting consumer tastes and trends following the epidemic.
Dermatological program started By ENTOD Pharma in India
ENTOD Pharmaceuticals and its UK sister company, ENTOD Beauty London Ltd., launched their dermatology venture in India. The nationwide sales field agent & distributor networks of Entod Pharmaceuticals will now sell ENTOD Beauty London goods in India.
Lupin Diagnostics opens a reference laboratory in Ranchi
Lupin Diagnostics opened its first Reference Laboratory in Ranchi, Jharkhand, as part of an announcement made by Lupin. The brand-new Reference Laboratory in Ranchi is set up to carry out a wide range of standard and specialty examinations.
USFDA designated Roche's Elecsys Amyloid Plasma Panel as breakthrough device
The Elecsys Amyloid Plasma Panel, a novel new method to enable earlier detection of Alzheimer’s disease, has received Breakthrough Device Designation from the US Food and Drug Administration (FDA),
